Back to Nephrology

OUR EXPERTISE AND SERVICES AVAILABLE IN

Glomerular Diseases

Overview

Spherix’s coverage of the glomerular disease market concentrates on the current treatment efforts, as well as the potential promising therapies on the horizon, for FSGS, IgA nephropathy, Alport Syndrome, and membranous nephropathy patients. Market trending reports coupled with patient chart audits and launch trackers provide unique and invaluable insights into these rapidly advancing markets.

Services Available

Exploring the patient journey

  • Alport Syndrome (US)

  • Focal Segmental Glomerulosclerosis (US)

  • IgA Nephropathy (US)

  • Membranous Nephropathy (US)

Service Info

RealWorld Dynamix™ is an independent, data-driven service unveiling real patient management patterns through rigorous analysis of large-scale patient chart audits. Insights reveal the “why” behind treatment decisions, include year over year trending to quantify key aspects of market evolution, and integrate specialists’ attitudinal & demographic data to highlight differences between stated and actual treatment patterns.

Report Methodology: Insights are based on patient level data gathered through collaboration with specialty physicians who provide details on clinical and non-clinical patient demographics, along with their rationale for treatment choices.

Sample Size and Frequency

US: annual patient chart audit (n=1,000 charts, n=200 physicians)

EU5: annual patient chart audit (n=1,250 charts, n=250 physicians)

Prepping for the pipeline

  • Alport Syndrome (EU)

  • Atypical Hemolytic Uremic Syndrome (US)

  • Complement Disorders (US)

  • Focal Segmental Glomerulosclerosis (FSGS) (US)

  • Focal Segmental Glomerulosclerosis (FSGS) (EU)

  • IgA Nephropathy (US)

  • IgA Nephropathy (EU)

  • Membranous Nephropathy (US)

  • Membranous Nephropathy (EU)

Service Info

Market Dynamix™ is an independent service providing analysis of markets anticipated to experience a paradigm shift within the next three to five years. Insights highlight market size, current treatment approaches, unmet needs, and expert opinions on the likely disruption introduced by pipeline agents.

Methodology: Insights are based on analyses of quantitative data collected from an online survey of specialists, patients, and leading KOLs recruited from the Spherix Network, as well as qualitative interviews conducted with a subset of survey respondents and select KOLs.

Sample Size and Frequency

Annual report (n=100-200 physicians)

Qualitative interviews (n=6-8 physicians, n=2-3 KOLs)

Benchmarking new brand performance

  • Tarpeyo (Calliditas) in IgA Nephropathy (US)

  • Bardoxolone Methyl (Reata) in Alport Syndrome (US)

Service Info

Launch Dynamix™ is an independent service providing monthly benchmarking of newly launched products for the first eighteen months of commercial availability, augmented by a quarterly deep dive into promotional activity, barriers to uptake, and patient types gravitating to the launch brand.

Methodology: Insights are based on analyses of quantitative data collected from an online survey of physicians “in the trenches” recruited from the Spherix Network, as well as qualitative interviews conducted with a subset of survey respondents.

Sample Size and Frequency

Monthly KPI benchmarking (n=75 physicians)

Quarterly report (n=75 physicians)

Quarterly qualitative interviews (n=8 physicians)

GAUGING IMPACT OF DISRUPTIVE EVENTS

  • Renal Pipeline Tracker

  • Feedback from ASN Conference 2022 (US)

  • Fellows and Residents (US)

Service Info

Special Topix™ is an independent service that includes access to a report or series of reports based on current events or topics of interest in specialty markets covered by Spherix.

Methodology: Insights are based on data collected from an online survey of respondents recruited from the Spherix Network, a proprietary group of specialty physicians in clinical practice meeting quality screening criteria.

Sample Size and Frequency

Report cadence and deliverable depend upon current event/topic being evaluated.

Learn more about our services

HOW CAN WE PARTNER TOGETHER?

Get more information on Glomerular Diseases Coverage